Regulations.gov document
Exhibit 26 - "Cubist Letter to FDA/CDER, September 14, 2000 re Change in Manufacturer…
Supporting & Related Material · FDA-2010-P-0624 · posted Feb 15, 2011
Key facts
| Document ID | FDA-2010-P-0624-0008 |
|---|---|
| Title | Exhibit 26 - "Cubist Letter to FDA/CDER, September 14, 2000 re Change in Manufacturer Procedure for Daptomycin API" - [Cubist Pharmaceuticals, Inc. - Supplement] re FDA-2010-P-0624-0005 |
| Document type | Supporting & Related Material |
| Subtype | SUP-Supplement (Supporting and Related Material) |
| Agency | FDA |
| Docket | FDA-2010-P-0624 |
| Posted | Feb 15, 2011 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: